Search
for
Sort by
Research 421–450 of 1000+
- 1,314
- AAPS and PSRC 2016 Abstract Supplement
- The 3D Bioprinted Scaffolds for Wound Healing
- Defective trophoblast function in mice with a targeted mutation of Ets2
- Chemical Composition and Biological Activities of Essential Oils of Curcuma Species
- A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: Ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome
- Advances in Chitosan-Based Nanoparticles for Drug Delivery
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Inherited ichthyoses/generalized Mendelian disorders of cornification
- The Potential of Ginkgo biloba as a Source of Biologically Active Compounds—A Review of the Recent Literature and Patents
- Oral isotretinoin for acne
- Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Jojoba Oil: An Updated Comprehensive Review on Chemistry, Pharmaceutical Uses, and Toxicity
- Long‐term safety and efficacy of bimatoprost solution 0·03% application to the eyelid margin for the treatment of idiopathic and chemotherapy‐induced eyelash hypotrichosis: a randomized controlled trial
- Ichthyosis with confetti: clinics, molecular genetics and management
- Black women’s hair: the main scalp dermatoses and aesthetic practices in women of African ethnicity
- “‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Bioengineered Skin Intended as In Vitro Model for Pharmacosmetics, Skin Disease Study and Environmental Skin Impact Analysis
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review
- Acetyl-CoA synthesis in the skin is a key determinant of systemic lipid homeostasis
- The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata
- Production of a Biosurfactant for Application in the Cosmetics Industry
- Therapeutic targeting of ocular diseases with emphasis on PI3K/Akt, and OPRL pathways by Hedera helix L. saponins: a new approach for the treatment of Pseudomonas aeruginosa-induced bacterial keratitis
- Assessment of Alopecia Areata Disease Severity in Pediatric Patients
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database